The Brain Health Imperative in the 21st Century-A Call to Action: The AAN Brain Health Platform and Position

Natalia S Rost1, Joel Salinas2, Justin T Jordan2

  • 1From the Department of Neurology (N.S.R., J.T.J.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Child Neurology (B.B.), Children's Hospital of Philadelphia; Departments of Neurology and Pediatrics (B.B), University of Pennsylvania, PA; Department of Neurology (J.S.), New York University Langone Health, New York University Grossman School of Medicine, New York, NY; Saul Korey Department of Neurology & Comprehensive Epilepsy Center (D.J.C.), Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Pediatrics, Division of Pediatric Neurology (R.R.S.), University of Texas Southwestern Medical Center, Dallas, TX; Department of Neurology (L.M.S.), University of Michigan Medical Center, Ann Arbor, MI; Department of Neurology (S.S.), Rush University Medical Center, Chicago, IL; and Texas Neurology (D.A.E.), Dallas. nrost@mgb.org.

Neurology
|September 20, 2023
PubMed
Abstract

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
47.5K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
677
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
155
Current Trends in Nursing I01:28

Current Trends in Nursing I

Current trends in nursing include:
1.5K